Fourteen cases of sarcomatous degeneration in Paget's disease

F Jattiot1, P Goupille, I Azais

  • 1Department of Rheumatology, Tours University, France.

Abstract

Insights

Sarcomatous degeneration in Paget's disease (SDP) is a rare but aggressive bone cancer. Early diagnosis and multimodal therapy are crucial for improving the poor prognosis of these challenging bone sarcomas.

Area of Science:

  • Oncology
  • Orthopedic Surgery
  • Radiology

Background:

  • Paget's disease of bone is a chronic condition.
  • Sarcomatous degeneration in Paget's disease (SDP) is a rare but serious complication.
  • SDP is associated with a poor prognosis compared to primary bone sarcomas.

Purpose of the Study:

  • To characterize cases of sarcomatous degeneration in Paget's disease (SDP).
  • To emphasize the magnetic resonance imaging (MRI) patterns of SDP.
  • To compare findings with existing literature.

Main Methods:

  • Retrospective analysis of 14 cases over 10 years from two French university hospitals.
  • Review of epidemiological, clinical, radiological, histological, and MRI data.
  • Comparison of collected data with published literature.

Main Results:

  • The study included 14 patients (9 men, 5 women, mean age 75.2 years).
  • Paget's disease was monostotic in 5 and polyostotic in 9 cases, with neurological complications in 10.
  • Common locations included the pelvis (7 cases) and sacrum (3 cases), with a predominantly lytic radiological pattern (9 cases). MRI showed a heterogeneous pattern (low T1, high T2 signal intensity). Histological investigation confirmed various types of bone sarcoma in 11/14 patients. Four patients developed pulmonary metastases.

Conclusions:

  • Sarcomas arising in Paget's disease (SDP) represent a highly aggressive bone malignancy.
  • The prognosis for SDP is significantly worse than for primary bone sarcomas.
  • Multimodal treatment strategies, including surgery, radiation, and chemotherapy, may improve outcomes for patients with SDP.

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...